A team of researchers has patented a mobile device that can monitor cancer quickly, cheaply, effectively and non-invasively
Researchers at the URV’s Department of Physical and Inorganic Chemistry, led by the ICREA researcher, Ramon Álvarez Puebla, and the professor of Applied Physics, Francesc Díaz, and the Department of Clinical Oncology of the HM Torrelodones University Hospital, have patented a portable device that can detect tumour cells in blood.
The device counts the number of tumour cells in a blood sample in real time and is thus a highly effective tool for improving the monitoring, treatment and diagnosis of cancer.
Very useful for clinical use
The system has been successfully tested on patients in various stages of breast cancer and could be used to determine the presence of other tumours by analysing different antibodies in the blood sample.
Patients with cancer, particularly if it has metastasised, need to be constantly monitored during treatment to assess the progress of the disease. This is currently done using imaging techniques and biopsies which are invasive and not always possible. In contrast, the device designed by the URV researchers is highly sensitive and requires no surgery or treatment involving radiation. It is thus a highly useful clinical method because it improves patient quality of life by removing the need for the more invasive traditional procedures.
The device will be a useful tool for accurately determining a patient’s level of health because it can monitor cancer quickly, cheaply, effectively and non-invasively. Furthermore, it can assist in the early diagnosis of the disease and monitor tumours more effectively and in a manner that has a less negative effect on patients’ bodies.
Two integrated systems
The new device uses two systems in miniature: a flow system and an optical system. The first causes the blood cells to flow in alignment, while the second uses two optic fibres (a laser diode and a photodetector) to analyse the cells and count those which are cancerous and those which are not. The ratio between the two gives an understanding as to how the cancer is progressing.
The Latest on: Cancer detection
- Judge shames and fines cancer patient for sloppy yardon January 17, 2022 at 7:02 pm
A father and son appeared for an online court appointment for a citation they received for their unkept yard in Michigan, but instead of a slap on the wrist from the judge, the father was berated.
- Tennis Legend Chris Evert Reveals Ovarian Cancer Diagnosison January 17, 2022 at 3:35 pm
Tennis hall of famer Chris Evert has revealed she is battling ovarian cancer. Evert, 67, lost her youngest sister to the disease nearly two years ago and that tragedy likely saved her life, CBS2’s Dr.
- Woman's cancer discovered after she questioned initial diagnosison January 17, 2022 at 3:20 pm
She was told she had an STD, but, it turned out to be skin cancer and she's very lucky she questioned the initial diagnosis.
- Tennis legend Chris Evert announces cancer diagnosison January 17, 2022 at 11:55 am
Evert posted on her verified Twitter account alongside a link to an ESPN article that she has stage 1 ovarian cancer.
- Dr. Ravi Patel discuss targeted therapy cancer treatments, PSMA testing for prostate cancer and early cancer detectionon January 17, 2022 at 11:30 am
Director of the Comprehensive Blood and Cancer Center (CBCC) Dr. Ravi Patel, joined 17 News at Sunrise to discuss targeted therapy cancer treatments. Dr. Patel ...
- Chris Evert's ovarian cancer diagnosis: What to know about preventionon January 17, 2022 at 11:22 am
Tennis legend Chris Evert recently revealed that she is battling stage 1C ovarian cancer. The 67-year-old tennis legend who has won 18 Grand Slam singles titles and three Grand Slam doubles titles ...
- What a terminal cancer diagnosis is teaching this neuroscientist about the human mindon January 17, 2022 at 9:20 am
Neuroscientist David J. Linden unpacks what he's learned about how the human mind works in the face of impending death.
- Can Breast Milk Detect Cancer? What New Research from Clarkson University Sayson January 17, 2022 at 8:34 am
Dr. Kathleen Arcaro, Dr. Roshanak Aslebagh and Dr. Costel Darie Potsdam, NY, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Samples from breast milk may one day be used routinely to identify cancer, or even to ...
- Tennis legend Chris Evert shares ovarian cancer diagnosison January 17, 2022 at 5:44 am
Chris Evert is opening up about her stage 1C ovarian cancer diagnosis, saying she hopes her story will help other women watch for warning signs. Evert is undergoing chemotherapy, but says she knows ...
- Tennis great Chris Evert reveals ovarian cancer diagnosison January 15, 2022 at 3:25 pm
Tennis great Chris Evert, winner of 18 Grand Slam singles titles, has revealed she is suffering from stage 1 ovarian cancer.
via Google News and Bing News